Kestra Medical Technologies (NASDAQ:KMTS) Now Covered by Piper Sandler

Piper Sandler initiated coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research report released on Monday morning, Marketbeat.com reports. The firm issued an overweight rating and a $27.00 price objective on the stock.

KMTS has been the topic of a number of other research reports. The Goldman Sachs Group began coverage on Kestra Medical Technologies in a research report on Monday. They issued a “neutral” rating and a $24.00 target price on the stock. Stifel Nicolaus began coverage on shares of Kestra Medical Technologies in a research report on Monday. They set a “buy” rating and a $28.00 price objective for the company. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Kestra Medical Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $27.67.

Kestra Medical Technologies Trading Up 6.4 %

Shares of KMTS opened at $24.92 on Monday. Kestra Medical Technologies has a 52-week low of $20.00 and a 52-week high of $25.98.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.